脑肠同治针刺疗法联合左归饮合逍遥散治疗肾虚肝郁型围绝经期抑郁症临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R749.4+2

基金项目:

浙江省中医药科技计划基金资助项目(2022ZB335);浙江省中青年临床名中医培养基金资助项目(浙中医药〔2021〕22号)


Clinical Study on Brain-Gut Co-treatment Acupuncture Combined with Zuogui Decoction plus Xiaoyao Powder in Treating Perimenopausal Depression of Kidney Deficiency and Liver Stagnation Type
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察脑肠同治针刺疗法联合左归饮合逍遥散治疗肾虚肝郁型围绝经期抑郁症的临床疗效及 对肠道菌群的影响。方法:选取2022年8月—2024年1月宁波市镇海区中医医院收治的120例肾虚肝郁型围绝 经期抑郁症患者,以随机数字表法分为针刺组和针药组各60例。2组均采用脑肠同治针刺疗法,针药组加用左 归饮合逍遥散治疗。2组均连续治疗4周。比较2组临床疗效和安全性,以及治疗前后改良Kupperman评分、匹 兹堡睡眠质量指数量表(PSQI) 评分、中医证候评分、生殖内分泌激素[雌激素(E2)、血清卵泡刺激素 (FSH)、促黄体生成素(LH)]、神经递质[5-羟色胺(5-HT)、去甲肾上腺素(NE)] 水平及肠道菌群组 成。结果:治疗后,针药组总有效率为86.67%(52/60),针刺组为66.67%(40/60),2组比较,差异有统计学 意义(P<0.05)。治疗后,2组改良Kupperman评分、PSQI评分及中医证候评分均较治疗前下降(P<0.05), 且针药组3项评分均低于针刺组(P<0.05)。治疗后,2组FSH、LH水平均较治疗前下降(P<0.05),且针药 组低于针刺组(P<0.05);2组E2水平均较治疗前上升(P<0.05),且针药组高于针刺组(P<0.05)。治疗后, 2组5-HT、NE水平均较治疗前上升(P<0.05),且针药组高于针刺组(P<0.05)。治疗后,2组乳酸杆菌、双 歧杆菌数量均较治疗前上升(P<0.05),且针药组菌群数量均高于针刺组(P<0.05);2组肠球菌、大肠埃希 菌数量均较治疗前下降(P<0.05),且针药组菌群数量均低于针刺组(P<0.05)。治疗期间,针药组不良反应 发生率为11.67%(7/60),针刺组为5.00%(3/60),2组比较,差异无统计学意义(P>0.05)。结论:脑肠同治 针刺疗法联合左归饮合逍遥散治疗肾虚肝郁型围绝经期抑郁症疗效显著,能有效改善生殖内分泌激素和神经递 质水平,调节肠道菌群分布。

    Abstract:

    Abstract: Objective: To observe the clinical efficacy of brain-gut co-treatment acupuncture combined with Zuogui Decoction plus Xiaoyao Powder in treating perimenopausal depression of kidney deficiency and liver stagnation type and its effects on gut microbiota. Methods: A total of 120 patients with perimenopausal depression of kidney deficiency and liver stagnation type treated at Zhenhai Hospital of Traditional Chinese Medicine from August 2022 to January 2024 were selected and divided into the acupuncture group and the acupuncture-medication group using the random number table method,with 60 cases in each group. Both groups received brain-gut co-treatment acupuncture therapy, while the acupuncture-medication group additionally received Zuogui Decoction plus Xiaoyao Powder. Both groups were treated continuously for four weeks. Clinical efficacy and safety were compared, along with modified Kupperman scores, Pittsburgh Sleep Quality Index(PSQI)scores, traditional Chinese medicine syndrome scores, levels of reproductive endocrine hormones [estradiol(E2),follicle-stimulating hormone(FSH),luteinizing hormone (LH)], levels of neurotransmitters [serotonin(5-HT),norepinephrine(NE)],and gut microbiota composition before and after treatment. Results: After treatment, the total effective rate was 86.67%(52 / 60) in the acupuncturemedication group, significantly higher than that of 66.67%(40/60)in the acupuncture group(P<0.05). Modified Kupperman scores, PSQI scores, and traditional Chinese medicine syndrome scores decreased in both groups compared to before treatment (P<0.05), with the acupuncture-medication group showing lower scores than the acupuncture group(P<0.05). After treatment, the FSH and LH levels decreased in both groups compared to before treatment(P<0.05),with the acupuncture-medication group showing lower levels than the acupuncture group(P< 0.05). After treatment, the E2 levels increased in both groups compared to before treatment(P<0.05), with the acupuncture-medication group showing higher levels than the acupuncture group(P<0.05). After treatment,the 5-HT and NE levels increased in both groups compared to before treatment(P<0.05),with the acupuncture-medication group showing higher levels than the acupuncture group (P<0.05). After treatment, the counts of Lactobacillus and Bifidobacterium increased in both groups compared to before treatment(P<0.05), with the acupuncture-medication group showing higher counts than the acupuncture group(P<0.05); the counts of Enterococcus and Escherichia coli decreased in both groups compared to before treatment(P<0.05), with the acupuncture-medication group showing lower counts than the acupuncture group(P<0.05). The incidence of adverse reactions was 11.67%(7/60)in the acupuncture-medication group and 5.00%(3/60)in the acupuncture group,with no significant difference between the two groups (P>0.05). Conclusion: Brain-gut co-treatment acupuncture combined with Zuogui Decoction plus Xiaoyao Powder is effective in treating perimenopausal depression of kidney deficiency and liver stagnation type, significantly improving reproductive neuroendocrine hormone and neurotransmitter levels and regulating gut microbiota distribution.

    参考文献
    相似文献
    引证文献
引用本文

董彩娟,徐裕亚,金燕娜,余锟,邓艳华.脑肠同治针刺疗法联合左归饮合逍遥散治疗肾虚肝郁型围绝经期抑郁症临床研究[J].新中医,2025,57(20):88-93

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-10-31
  • 出版日期:
文章二维码